forecast
mRNA Vaccines as the Insulin Moment for a New Drug Class
Jason argues that the Moderna and BioNTech RNA vaccines, with about 95% efficacy, mark a turning point comparable to Genentech's insulin in 1978, opening a new drug category based on nucleic acids.
forecastpending
Speaker
Jason KellyEvidence Quote
“To me, that is Genentech and insulin all over again, but for a whole new category of drugs.”
Created: 11/15/2026, 7:57:10 PM
Your notes
Loading notes...